Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124218224 | 12421822 | 4 | F | 20160516 | 20160726 | 20160531 | 20160802 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-042799 | BRISTOL MYERS SQUIBB | 48.80 | YR | F | Y | 0.00000 | 20160802 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124218224 | 12421822 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 1 TAB, QD | 2100 | MG | 5J83183B,5K86272B | 21986 | 1 | DF | FILM-COATED TABLET | QD | |||
| 124218224 | 12421822 | 2 | SS | SPRYCEL | DASATINIB | 1 | Oral | 100 MG, UNK | 2100 | MG | 21986 | 100 | MG | FILM-COATED TABLET | QD | ||||
| 124218224 | 12421822 | 3 | SS | SPRYCEL | DASATINIB | 1 | Oral | 100 MG, UNK | 2100 | MG | 21986 | 100 | MG | FILM-COATED TABLET | QD | ||||
| 124218224 | 12421822 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
| 124218224 | 12421822 | 5 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | 0 | ||||||||||
| 124218224 | 12421822 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
| 124218224 | 12421822 | 7 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
| 124218224 | 12421822 | 8 | C | NADOLOL. | NADOLOL | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
| 124218224 | 12421822 | 9 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Unknown | UNK, QD | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124218224 | 12421822 | 1 | Chronic myeloid leukaemia |
| 124218224 | 12421822 | 4 | Product used for unknown indication |
| 124218224 | 12421822 | 5 | Product used for unknown indication |
| 124218224 | 12421822 | 6 | Product used for unknown indication |
| 124218224 | 12421822 | 7 | Product used for unknown indication |
| 124218224 | 12421822 | 8 | Product used for unknown indication |
| 124218224 | 12421822 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124218224 | 12421822 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124218224 | 12421822 | Dyspnoea | |
| 124218224 | 12421822 | Headache | |
| 124218224 | 12421822 | Hypoaesthesia | |
| 124218224 | 12421822 | Migraine | |
| 124218224 | 12421822 | Pulmonary oedema | |
| 124218224 | 12421822 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124218224 | 12421822 | 1 | 20160415 | 0 | ||
| 124218224 | 12421822 | 2 | 20160426 | 20160607 | 0 | |
| 124218224 | 12421822 | 3 | 20160625 | 0 |